MIC
GILD icon

Meridian Investment Counsel’s Gilead Sciences GILD Stock Holding History

Meridian Investment Counsel’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.97M Sell
31,450
-700
-2% -$92.2K 0.85% 28
2026
Q1 		$4.48M Buy
32,150
+30
+0.1% +$4.2K 1.07% 18
2025
Q4 		$3.94M Buy
32,120
+10,953
+52% +$1.33M 0.95% 27
2025
Q3 		$2.35M Hold
21,167
– – 0.58% 54
2025
Q2 		$2.35M Hold
21,167
– – 0.64% 48
2025
Q1 		$2.37M Sell
21,167
-200
-0.9% -$20.6K 0.7% 43
2024
Q4 		$1.97M Sell
21,367
-205
-1% -$18.5K 0.59% 48
2024
Q3 		$1.81M Sell
21,572
-2,100
-9% -$160K 0.55% 58
2024
Q2 		$1.62M Sell
23,672
-190
-0.8% -$12.7K 0.51% 62
2024
Q1 		$1.75M Sell
23,862
-197
-0.8% -$15.1K 0.58% 54
2023
Q4 		$1.95M Sell
24,059
-350
-1% -$27.2K 0.67% 45
2023
Q3 		$1.83M Sell
24,409
-800
-3% -$61.5K 0.69% 42
2023
Q2 		$1.94M Hold
25,209
– – 0.69% 43
2023
Q1 		$2.09M Sell
25,209
-200
-0.8% -$16.6K 0.79% 37
2022
Q4 		$2.18M Sell
25,409
-625
-2% -$49.5K 0.87% 33
2022
Q3 		$1.61M Sell
26,034
-125
-0.5% -$7.88K 0.71% 40
2022
Q2 		$1.62M Sell
26,159
-1,142
-4% -$70.7K 0.66% 43
2022
Q1 		$1.62M Hold
27,301
– – 0.56% 50
2021
Q4 		$1.98M Sell
27,301
-275
-1% -$18.9K 0.66% 39
2021
Q3 		$1.93M Sell
27,576
-550
-2% -$38.6K 0.7% 39
2021
Q2 		$1.94M Buy
28,126
+95
+0.3% +$6.34K 0.68% 39
2021
Q1 		$1.81M Sell
28,031
-100
-0.4% -$6.45K 0.7% 39
2020
Q4 		$1.64M Sell
28,131
-550
-2% -$33.2K 0.69% 38
2020
Q3 		$1.81M Sell
28,681
-100
-0.3% -$6.93K 0.88% 31
2020
Q2 		$2.21M Buy
28,781
+205
+0.7% +$15.7K 1.13% 23
2020
Q1 		$2.14M Sell
28,576
-700
-2% -$48.4K 1.39% 20
2019
Q4 		$1.9M Sell
29,276
-300
-1% -$19.5K 0.94% 31
2019
Q3 		$1.88M Sell
29,576
-150
-0.5% -$9.8K 1.02% 28
2019
Q2 		$2.01M Sell
29,726
-11
-0% -$724 1.11% 27
2019
Q1 		$1.93M Sell
29,737
-700
-2% -$46.5K 1.13% 29
2018
Q4 		$1.9M Sell
30,437
-300
-1% -$21K 1.25% 27
2018
Q3 		$2.37M Sell
30,737
-120
-0.4% -$9.06K 1.3% 24
2018
Q2 		$2.19M Buy
30,857
+50
+0.2% +$3.53K 1.23% 23
2018
Q1 		$2.32M Buy
30,807
+3,050
+11% +$242K 1.32% 20
2017
Q4 		$1.99M Buy
27,757
+5,110
+23% +$388K 1.08% 33
2017
Q3 		$1.83M Buy
22,647
+800
+4% +$61.2K 1.06% 31
2017
Q2 		$1.55M Buy
21,847
+2,746
+14% +$183K 0.92% 37
2017
Q1 		$1.3M Buy
19,101
+9,330
+95% +$656K 0.8% 42
2016
Q4 		$700K Buy
9,771
+375
+4% +$27.9K 0.47% 68
2016
Q3 		$743K Buy
9,396
+2,016
+27% +$164K 0.5% 65
2016
Q2 		$616K Buy
7,380
+2,666
+57% +$237K 0.42% 73
2016
Q1 		$433K Buy
4,714
+2,655
+129% +$239K 0.3% 97
2015
Q4 		$208K Buy
+2,059
New +$214K 0.15% 149

Other funds holding GILD

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Meridian Investment Counsel's GILD Position: Q2 2026 in Review

Meridian Investment Counsel reduced its Gilead Sciences (GILD) stake by 2.2% in Q2 2026, selling an estimated $92.2K and leaving 31,450 shares worth $3.97M. The position accounts for 0.85% of the portfolio, ranked #28.

Meridian Investment Counsel first reported a position in GILD in Q4 2015 and has held it in 43 quarters since. The position peaked at $4.48M in Q1 2026. 1,064 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Meridian Investment Counsel held 31,450 shares of Gilead Sciences worth $3.97M as of Q2 2026.
  • Meridian Investment Counsel sold 700 Gilead Sciences shares in Q2 2026, an estimated $92.2K.
  • Gilead Sciences made up 0.85% of Meridian Investment Counsel's portfolio in Q2 2026, its #28 holding.
  • Meridian Investment Counsel first reported a position in Gilead Sciences in Q4 2015 and has held it in 43 quarters since.
  • Meridian Investment Counsel's Gilead Sciences position peaked at $4.48M in Q1 2026.
  • 1,064 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Meridian Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.